Novartis Pharms. Corp. v. Accord Healthcare, Inc.

[Anonymous]

BIOTECHNOLOGY LAW REPORT, 2022; 41 (4): 204

Abstract

In this case the Federal Circuit granted the accused infringers' petition for panel rehearing, vacated its prior decision, and reversed the district c......

Full Text Link